Glunz & Jensen Holding A/S
19.8.2026 13:43:07 CEST | Globenewswire | Press release
H1, 2026 reporting
H1, 2026 reporting
To Nasdaq OMX Copenhagen A/S
Company announcement no. 592
August 19th, 2026
INTERIM REPORT JANUARY 1ST, 2026 – JUNE 30TH, 2026 (H1 2026)
The H1 2026 report for the fiscal year was reviewed and approved at the Board of Directors meeting.
Highlights
- Overall, the H1, 2026 came out weaker than expected and below the performance of H1, 2025. The topline and in part the bottom-line were negatively impacted by customers delaying pickup of equipment equal to postponed revenue of DKK 7,6 million. The postponement to H2, 2026 lowered the EBITDA and Profit before tax in H1, 2026 by DKK 2,3 million and increased inventories by June 30th, 2026.
- The revenue for H1 2026 amounted to DKK 67,0 million (H1 2025: DKK 74,5 million).
- The gross profit amounted to DKK 18,2 million in H1 2026 (H1 2025: DKK 19,6 million), the gross profit margin was 27,2% (H1 2025: 26,3%).
- EBITDA for the period was DKK 8,4 million (H1 2025: DKK 9,5 million).
- Profit before tax for the period H1 2026 was DKK 5,6 million (H1 2025: DKK 6,3 million), corresponding to a result per share (EPS) at DKK 2,4 (H1 2025: DKK 2,7).
Glunz & Jensen continuously monitors its financial performance and will communicate an updated 2026 outlook (guidance) in the event of any material deviations from the already communicated outlook dated February 23rd, 2026. At present, the 2026 outlook is unchanged.
Pursuant to the mandate granted at the Annual General Meeting on April 9th, 2025, regarding a potential sale of Selandia Park A/S or its assets, primarily the investment property, Glunz & Jensen Holding A/S has appointed a new commercial real estate broker with effect from August 1st, 2026. The change has been made to increase the likelihood of a successful transaction. The sales process is, however, still expected to take approximately 12-18 months, depending on market conditions and buyer interest. Glunz & Jensen Holding A/S will keep the market informed of any material developments.
For further information please contact:
CEO Henrik Blegvad Funk: phone +45 21 39 05 32
Chairman of the board Flemming Nyenstad Enevoldsen: phone +45 40 43 13 03
Attachments
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Shufti Pro Limited19.8.2026 16:00:00 CEST | Press release
Shufti Helps Obliged Entities Get Ready for the EU AMLR Ahead of the July 2027 Deadline
Cosmos Health Inc.19.8.2026 15:00:00 CEST | Press release
Cosmos Health Reports Q2 2026 Results: Record Q2 and H1 Revenue of $19.0M and $36.9M, Up 29% and 30%; Q2 Adjusted Gross Profit Up 58%; Total Liabilities Reduced 13%; Stockholders' Equity Up 12%; $5M Share Repurchase Program Underway
Teva Pharmaceutical Industries Ltd19.8.2026 14:30:00 CEST | Press release
U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Patients with Tourette Syndrome
Exclaimer Ltd.19.8.2026 14:00:00 CEST | Press release
Exclaimer Launches MSP Connect to Remove Billing and Management Friction for MSPs
Aduro Clean Technologies Inc.19.8.2026 14:00:00 CEST | Press release
Aduro Selects Saipem for Engineering and Procurement Support for First-of-a-Kind HCT Facility at Chemelot
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom